𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Routine bone scintigraphy is of limited value in the clinical assessment of untreated patients with Hodgkin's disease

✍ Scribed by O Landgren; U Axdorph; H Jacobsson; B Johansson; G Grimfors; M Björkholm


Publisher
Springer US
Year
2000
Tongue
English
Weight
448 KB
Volume
17
Category
Article
ISSN
1357-0560

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Value of Doppler sonography in the asses
✍ Gorka, Waldemar; Lewall, David B. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 2 views

Purpose. We examined the intracystic flow pattern and portal hemodynamics with Doppler sonography in patients with Caroli's disease. Methods. Sonographic characteristics and portal hemodynamics were studied by color Doppler sonography and spectral analysis in 5 patients (4 children and 1 adult) wit

Serum CA 125 is of clinical value in the
✍ Ikram A. Burney; Tariq Siddiqui; Imran Siddiqui 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 3 views

W e read with interest the article published in Cancer earlier this year regarding the elevation of CA 125 in patients with non-Hodgkin's lymphoma and its normalization with clinical response. 1 Earlier a case report had also emerged about elevation of CA 125 in a patient within tuberculous peritoni

Serum CA 125 is of clinical value in the
✍ Mario Lazzarino; Ester Orlandi; Catherine Klersy; Cesare Astori; Ercole Brusamol 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 3 views

## Background: Ca 125 is a glycoprotein produced by epithelial ovarian tumors and by mesothelial cells; its levels also have been shown to be elevated in patients with non-hodgkin's lymphoma (nhl). ## Methods: The authors evaluated serum ca 125 levels in patients with nhl to elucidate the frequen

Clinical relevance of electrophysiologic
✍ Jean-Pascal Lefaucheur; Anne-Catherine Bachoud-Levi; Catherine Bourdet; Thierry 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB

Assessment programs recently designed to follow-up patients with Huntington's disease (HD) in therapeutic trials have not included electrophysiological testing in the list of mandatory examinations. This omission is likely due to the current lack of data establishing a clear correlation between the